Elizabeth Hougen
Director of Finance/CFO chez IONIS PHARMACEUTICALS, INC.
Fortune : 4 M $ au 31/03/2024
Profil
Actuellement, Elizabeth L. Hougen est Chief Financial Officer & SVP-Finance chez Ionis Pharmaceuticals, Inc. et Treasurer & Director chez Akcea Therapeutics, Inc. (une filiale de Ionis Pharmaceuticals, Inc.). Dans le passé, Mme Hougen a occupé le poste de directrice financière et de directrice exécutive chez Molecular Biosystems, Inc. et celui de directrice financière et de responsable de la comptabilité chez Akcea Therapeutics, Inc. Mme Hougen est titulaire d'un MBA de l'université de San Diego et d'un diplôme de premier cycle du Franklin & Marshall College.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 02/02/2024 | 92 905 ( 0,06% ) | 4 M $ | 31/03/2024 |
Postes actifs de Elizabeth Hougen
| Sociétés | Poste | Début |
|---|---|---|
| IONIS PHARMACEUTICALS, INC. | Director of Finance/CFO | 01/05/2000 |
Artiva Biotherapeutics, Inc.
 Artiva Biotherapeutics, Inc. BiotechnologyHealth Technology Artiva Biotherapeutics, Inc. operates as a biotechnology company for the treatment of hematologic cancers. It offers NK cell therapies for cancer. The company was founded by Thomas J. Farrell in 2019 and is headquartered in San Diego, CA. | Director/Board Member | 19/05/2021 |
Anciens postes connus de Elizabeth Hougen
| Sociétés | Poste | Fin |
|---|---|---|
| AKCEA THERAPEUTICS, INC. | Director of Finance/CFO | 31/08/2017 |
Molecular Biosystems, Inc.
 Molecular Biosystems, Inc. Medical SpecialtiesHealth Technology Molecular Biosystems, Inc. develops, makes and sells ultrasound contrast imaging agents. The company was founded by Kenneth J. Widder, Richard H. Tullis, Drew E. Senyei and Lyle J. Arnold and is headquartered in San Diego, CA. | Director of Finance/CFO | 01/01/2000 |
| AKCEA THERAPEUTICS, INC. | Director/Board Member | - |
Formation de Elizabeth Hougen
| Franklin & Marshall College | Undergraduate Degree |
| University of San Diego | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| IONIS PHARMACEUTICALS, INC. | Health Technology |
| Entreprise privées | 3 |
|---|---|
Molecular Biosystems, Inc.
Molecular Biosystems, Inc. Medical SpecialtiesHealth Technology Molecular Biosystems, Inc. develops, makes and sells ultrasound contrast imaging agents. The company was founded by Kenneth J. Widder, Richard H. Tullis, Drew E. Senyei and Lyle J. Arnold and is headquartered in San Diego, CA. | Health Technology |
Akcea Therapeutics, Inc.
 Akcea Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Akcea Therapeutics, Inc. is a biopharmaceutical company. It engages in the development and marketing of drugs globally to treat patients with rare and serious diseases using antisense technology. Its primary focus is developing TEGSEDI, a therapy that treats the polyneuropathy caused by hereditary transthyretin-mediated amyloidosis in adults. It also offers a mature pipeline of novel drugs including AKCEA-APO(a)-LRx, AKCEA-ANGPTL3-LRx, and AKCEA-APOCIII-LRx. The company was founded in December 2014 and is headquartered in Cambridge, MA. | Health Technology |
Artiva Biotherapeutics, Inc.
Artiva Biotherapeutics, Inc. BiotechnologyHealth Technology Artiva Biotherapeutics, Inc. operates as a biotechnology company for the treatment of hematologic cancers. It offers NK cell therapies for cancer. The company was founded by Thomas J. Farrell in 2019 and is headquartered in San Diego, CA. | Health Technology |
